SciBase and Castle Biosciences Begin Study on Predicting Atopic Dermatitis Flares

June 10, 2026
SciBase and Castle Biosciences have enrolled the first patient in a clinical study evaluating the use of electrical impedance spectroscopy to predict flare-ups in atopic dermatitis.

SciBase and Castle Biosciences have enrolled the first patient in a new clinical study focused on predicting flare-ups in atopic dermatitis, announced in a press release.

The multicenter prospective study, named DETECT-AD, will evaluate SciBase's electrical impedance spectroscopy method for its ability to predict the onset of flares in patients with atopic dermatitis. The study aims to identify early signs of flare-ups to support proactive care and improve patient management.

Atopic dermatitis is a chronic skin condition characterized by alternating periods of remission and flare-ups. Current treatments are typically reactive, addressing symptoms after they appear. The DETECT-AD study seeks to move toward predictive and personalized care by using early detection data.

Pia Renaudin, CEO of SciBase, said the enrollment of the first patient marks a key milestone in the company's collaboration with Castle Biosciences to enhance management of atopic dermatitis.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

06/10
XFERALL Launches AI Powered Patient Intake Suite for Behavioral Health Transfers
06/10
Aignostics and PanCAN Collaborate on AI Spatial Profiling for Pancreatic Cancer Research
06/10
UC Davis Launches AggieBrain AI Neuropathology Initiative with $420,500 Donation
06/10
PartsSource Acquires SkillNet to Add Workforce Intelligence to Clinical Technology Platform
06/10
Ambitious Bio Emerges from Stealth to Build Foundational Biological Data Infrastructure

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like